Related Experiment Video
Updated: Dec 11, 2025
10:15
Proteomic Analysis of Human Macrophage Polarization Under a Low Oxygen Environment
Published on: January 7, 2019
8.3K
Proteomics Network Analysis of Polarized Macrophages
Jayanta K Chakrabarty1, Abu Hena Mostafa Kamal1, A D A Shahinuzzaman1
1Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|August 19, 2020
Summary
This study details methods for analyzing macrophage inflammation using proteomics. It explores how lipopolysaccharides (LPS) and statins impact inflammatory protein networks in immune cells.
Area of Science:
- Immunology
- Proteomics
- Pharmacology
Background:
- Macrophages are key immune cells in innate immunity, utilizing Toll-like receptor (TLR) signaling.
- Lipopolysaccharides (LPS) activate macrophages via TLRs, leading to pro-inflammatory cytokine production.
- Statins, used for hypercholesterolemia, can mitigate inflammatory responses.
Purpose of the Study:
- To establish protocols for studying the inflammatory proteomics network in RAW 264.7 macrophage cells.
- To investigate the effects of singular and sequential treatment with LPS and statin on macrophage protein networks.
- To provide a comprehensive methodology for proteomic and bioinformatic analysis of inflammatory responses.
Main Methods:
- Quantitative proteomics using mass spectrometry to analyze protein expression.
- Bioinformatic analysis for protein network and interaction mapping.
- Biochemical validation including immunocytochemistry, immunoblotting, gene silencing, and real-time PCR.
Main Results:
- Detailed protocols for quantitative proteomic analysis of macrophage inflammatory responses.
- Methodology for protein network analysis to understand LPS and statin interactions.
- Validation strategies for identified target proteins and pathways.
Conclusions:
- The described protocols enable in-depth study of macrophage inflammatory networks.
- This approach facilitates understanding of how LPS and statins modulate immune responses at the proteomic level.
- The methodology supports discovery of novel therapeutic targets for inflammatory diseases.
